Live Breaking News & Updates on Meibomian gland disease

Stay updated with breaking news from Meibomian gland disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tarsus Pharmaceuticals (TARS) Added to NASDAQ Biotechnology Index

Tarsus Pharmaceuticals (TARS) Added to NASDAQ Biotechnology Index
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Adrienne-kempsr , Exchange-commission , Us-food-drug-administration , Corporate-communications , Tarsus-pharmaceuticals-inc , Biotechnology-index-fund , Nasdaq , Wall-street , Nasdaq-stock , Index-fund , Tarsus-pharmaceuticals

Tarsus Pharmaceuticals (TARS) Reports Positive Topline Data from Phase 1b Callisto Trial, Initiates Phase 2a Carpo Human Tick Kill Trial

Tarsus Pharmaceuticals (TARS) Reports Positive Topline Data from Phase 1b Callisto Trial, Initiates Phase 2a Carpo Human Tick Kill Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Americans , David-nakasone , Adrienne-kemp , Centers-for-disease , Tarsus-pharmaceuticals-inc , Drug-administration , Nasdaq , Exchange-commission , Us-food-drug-administration , Corporate-communications , Carpo-phase

The Scratchy, Gritty, Misery of Dry Eye Disease

Dry eye disease may not sound serious, but the results can be devastating. Some sufferers always feel like there is something stuck in their eyes.

Australia , United-states , United-kingdom , Americans , Australian , American , British , Vectormine-shutterstock , Christophe-baudouin , Lauram-periman , Vanderbilt-university , United-states-health-care-system

Tarsus Pharmaceuticals (TARS) Announces Board Transition Plans

Tarsus Pharmaceuticals (TARS) Announces Board Transition Plans
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michael-ackermann , David-nakasone , Adrienne-kemp , Bobak-azamian , Wendy-yarno , Tarsus-co , Tarsus-pharmaceuticals-inc , Wendy , Nasdaq , Exchange-commission , Us-food-drug-administration

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Illinois , Chicago , Americans , American , Elizabeth-yeu , Demodex-blepharitisblepharitis , Adrienne-kempsr , Lisa-nijm , Tarsus-pharmaceuticals-inc , Drug-administration , American-academy-of-ophthalmology

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Americans , Demodex-blepharitisblepharitis , Adrienne-kempsr , Exchange-commission , Corporate-communications , Tarsus-pharmaceuticals-inc , Drug-administration , Nasdaq , Wall-street , Meibomian-gland-disease , New-drug-application

Sight Sciences : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K

Sight Sciences Reports Fourth Quarter and Full Year 2021 Financial Results


MENLO PARK, Calif., March 24, 2022 -- Sight Sciences, Inc. , an eyecare technology company focused on... | March 24, 2022

Philip-taylor , Paul-badawi , Shay-smith , Brenda-becker , Nasdaq , Exchange-commission , Company-tearcare , Gilmartin-group , Sight-sciences-reports-fourth-quarter , Securities-exchange , Sight-sciences